Ovarian Tissue Cryopreservation and Subsequent Auto-Transplantation for Female Cancer Patients

Recruiting now · Not applicable

Conditions studied: Neoplasms

In brief

Ovarian Tissue Cryopreservation will be provided to cancer patients to allow them to have their fertility preserved.

Key facts

Study ID

NCT05830929

Run by

Chinese University of Hong Kong

People needed

100

Starts

2023-08-01

Expected to finish

2043-12-30

Last updated by the study team

2026-01-07

Who can join

Age: 0 and older, up to 35. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Patients aged from 0-35 years old and diagnosed with cancer e.g., leukaemia, myeloproliferative or myelodysplastic diseases, lymphoma, bone tumours, neurological neoplasms and sarcoma, Paediatric bone marrow transplant patients
• Patients with any illness or who will undergo any type of treatment that may cause irreversible damage to their fertility, such as extensive abdominal surgery, high toxicity medication and treatments;
• Patients suffering from hormone-sensitive malignancies who will undergo medical treatment, such as radiotherapy and chemotherapy that is liable to damage their ovaries and deter them from conception in the future.

You may not qualify if…

• Patients with no anticipated oncologic therapies
• Patients who are pregnant
• Children with one ovary
• Children deemed high risk for perioperative complications
• Patients unable to provide consent/assent (i.e. significant psychiatric problems/cognitive delay)

Where it is running

• Prince of Wales Hospital — Hong Kong, Hong Kong (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.